The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Parameter adaptations during phenotype transitions in progressive diseases
Open accessAbstract
BACKGROUND: The study of phenotype transitions is important to understand progressive diseases, e.g., diabetes mellitus, metabolic syndrome, and cardiovascular diseases. A challenge remains to explain phenotype transitions in terms of adaptations in molecular components and interactions in underlying biological systems. RESULTS: Here, mathematical modeling is used to describe the different phenotypes by integrating experimental data on metabolic pools and fluxes. Subsequently, trajectories of parameter adaptations are identified that are essential for the phenotypical changes. These changes in parameters reflect progressive adaptations at the transcriptome and proteome level, which occur at larger timescales. The approach was employed to study the metabolic processes underlying liver X receptor induced hepatic steatosis. Model analysis predicts which molecular processes adapt in time after pharmacological activation of the liver X receptor. Our results show that hepatic triglyceride fluxes are increased and triglycerides are especially stored in cytosolic fractions, rather than in endoplasmic reticulum fractions. Furthermore, the model reveals several possible scenarios for adaptations in cholesterol metabolism. According to the analysis, the additional quantification of one cholesterol flux is sufficient to exclude many of these hypotheses. CONCLUSIONS: We propose a generic computational approach to analyze biological systems evolving through various phenotypes and to predict which molecular processes are responsible for the transition. For the case of liver X receptor induced hepatic steatosis the novel approach yields information about the redistribution of fluxes and pools of triglycerides and cholesterols that was not directly apparent from the experimental data. Model analysis provides guidance which specific molecular processes to study in more detail to obtain further understanding of the underlying biological system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Additionally relying on measurements that were performed in vitro can lead to inaccuracies [35] due to differences in the biochemical environment and regulatory mechanisms that were not accounted for [16].”
From Parameter uncertainty in biochemical models described by ordinary differential equations (2013) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple comparisons among means
Dunn, O. J. (1961) · Journal of the American Statistical Association · doi:10.1080/01621459.1961.10482090 · Cited by 5,006 · cited 1×
“05, adjusted by Bonferroni correction to account for the number of comparisons being performed (number of model outputs), was used [35].”
MethodType 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737 · cited 1×
“Cardiovascular and metabolic diseases such as diabetes mellitus and metabolic syndrome are progressive in time [1-5].”
BackgroundComputational systems biology.
Kitano, H. (2002) · Nature · doi:10.1038/nature01254 · Cited by 2,209
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591 · cited 1×
“LXRs, when ligand-activated by oxysterols, heterodimerize with the retinoid X receptor (RXR) and bind to LXR responsive elements on the DNA [27], where they induce the transcription of lipogenic genes such as SREBP-1C, FAS, ABCA1, and ACC1.”
BackgroundRole of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499 · cited 2×
“Model predictions indicate that the production of apolipoprotein B decreases slightly, which was also observed by [29,30,46].”
BackgroundRaue, A., Kreutz, C., Maiwald, T., Bachmann, J., Schilling, M., Klingmüller, U., & Timmer, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp358 · Cited by 1,442 · cited 1×
“To assess the uncertainty associated with model predictions, differences between feasible parameter sets must be examined [32-34].”
BackgroundUniversally Sloppy Parameter Sensitivities in Systems Biology Models
Gutenkunst, R. N., Waterfall, J. J., Casey, F. P., Brown, K. S., Myers, C. R., & Sethna, J. P. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030189 · Cited by 1,261 · cited 1×
“To assess the uncertainty associated with model predictions, differences between feasible parameter sets must be examined [32-34].”
BackgroundReciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158 · cited 1×
“The approach, which is applicable to a multitude of biological systems, is demonstrated on the basis of a case involving the activation of the liver X receptor (LXR), a promising drug target for atherosclerotic therapies [25,26].”
BackgroundCases, S., Smith, S. J., Zheng, Y.-W., Myers, H. M., Lear, S. R., Sande, E., Novak, S., Collins, C., Welch, C. B., Lusis, A. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13018 · Cited by 1,123 · cited 1×
“A relevant follow-up study would be to determine whether these differences are associated with alterations in diglyceride acyltransferase activities (DGAT1 and DGAT2), which play a crucial role in the biosynthesis and deposition of triglycerides [56-59].”
BackgroundThematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis
Yen, C.-L. E., Stone, S. J., Koliwad, S., Harris, C., & Farese, R. V. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800018-jlr200 · Cited by 1,105
Cited by
Regulation of cholesterol homeostasis
van der Wulp, M. Y. M., Verkade, H. J., & Groen, A. K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.007 · Cited by 205
“More recently, Tiemann et al. published a quite elaborate computational model that includes both TG and cholesterol metabolism and adequately predicts the levels of both plasma cholesterol and TG levels in wild type mice with and without activation of LXR (Tiemann et al., 2011).”
BackgroundInfluentialParameter uncertainty in biochemical models described by ordinary differential equations
Vanlier, J., Tiemann, C. A., Hilbers, P. A. J., & van Riel, N. A. W. (2013) · Mathematical Biosciences · doi:10.1016/j.mbs.2013.03.006 · Cited by 116
Self-citationA bayesian approach to targeted experiment design
Vanlier, J., Tiemann, C. A., Hilbers, P. A. J., & van Riel, N. A. W. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts092 · Cited by 98
“We employ a Bayesian approach involving importance sampling of the posterior predictive distribution to predict the efficacy of a new measurement at reducing the uncertainty of a selected prediction.”
MethodSelf-citationModeling autism: a systems biology approach
Randolph-Gips, M. M., & Srinivasan, P. N. (2012) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-2-17 · Cited by 49
“Frameworks have been developed for parameter adjustments during phenotype transitions [169].”
Optimal experiment design for model selection in biochemical networks
Vanlier, J., Tiemann, C. A., Hilbers, P. A. J., & van Riel, N. A. W. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-20 · Cited by 55
“Developing computational models of biochemical networks is complicated by the complexity of their interaction mechanisms [1-8].”
Self-citation
Metadata
- Authors
- Tiemann, C. A., Vanlier, J., Hilbers, P. A., & van Riel, N. A.
- Affiliations
- Eindhoven University of Technology (NL)
- Corresponding author
- Tiemann, Christian A
- ORCID
- Hilbers, Peter AJ
- Venue
- BMC Systems Biology
- Published
- 2011
- Volume
- 5
- Issue
- 1
- Pages
- 174
- ISSN
- 1752-0509 (ISSN-L)
- PMC
- PMC3354367
- OpenAlex
- W1999787554
- Cited by
- 22
- References
- 66
- Citations by year
- 2022: 2 · 2021: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 4
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Systems Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TU/e Research Portal (publishedVersion, other-oa)
- TU/e Research Portal (submittedVersion)
- TU/e Research Portal (submittedVersion, other-oa)
- Funders
- Universiteit van Amsterdam
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- phenotype transition, progressive disease, parameter adaptation, metabolic flux analysis, liver X receptor, hepatic steatosis, triglyceride metabolism, cholesterol metabolism, metabolic pools, metabolic modeling
- MeSH terms
- Liver X Receptors, Animals, Computer Simulation, Fatty Liver, Mice, Inbred C57BL, Models, Biological, Phenotype, Computational Biology, Systems Biology, Mice, Metabolic Networks and Pathways, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Parameter adaptations during phenotype transitions in progressive diseases. https://app.cochat.ai/papers/10.1186/1752-0509-5-174
- The paper
- Tiemann, C. A., Vanlier, J., Hilbers, P. A., & van Riel, N. A. (2011). Parameter adaptations during phenotype transitions in progressive diseases. BMC Systems Biology. https://doi.org/10.1186/1752-0509-5-174
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.